Osaic Holdings
DNLI icon

Osaic Holdings’s Denali Therapeutics DNLI Stock Holding History

Osaic Holdings’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
17,016
+603
+4% +$12.4K ﹤0.01% 3770
2026
Q1 		$315K Buy
16,413
+15,339
+1,428% +$305K ﹤0.01% 3782
2025
Q4 		$17.7K Sell
1,074
-314
-23% -$5.3K ﹤0.01% 5950
2025
Q3 		$20.9K Sell
1,388
-207
-13% -$2.97K ﹤0.01% 5901
2025
Q2 		$22.2K Buy
1,595
+547
+52% +$7.7K ﹤0.01% 5621
2025
Q1 		$14.3K Sell
1,048
-545
-34% -$10.4K ﹤0.01% 5585
2024
Q4 		$32.5K Buy
1,593
+296
+23% +$7.58K ﹤0.01% 5013
2024
Q3 		$37.8K Buy
1,297
+447
+53% +$11.1K ﹤0.01% 4941
2024
Q2 		$19.7K Buy
850
+211
+33% +$4.05K ﹤0.01% 5354
2024
Q1 		$13.1K Sell
639
-873
-58% -$16.4K ﹤0.01% 5603
2023
Q4 		$32.4K Sell
1,512
-3,165
-68% -$62.7K ﹤0.01% 5187
2023
Q3 		$96.5K Buy
4,677
+2,478
+113% +$62.9K ﹤0.01% 4535
2023
Q2 		$64.9K Sell
2,199
-119
-5% -$3.35K ﹤0.01% 4763
2023
Q1 		$53.4K Buy
2,318
+98
+4% +$2.7K ﹤0.01% 4902
2022
Q4 		$61.6K Sell
2,220
-610
-22% -$18.1K ﹤0.01% 4782
2022
Q3 		$87K Buy
2,830
+566
+25% +$18.4K ﹤0.01% 4486
2022
Q2 		$66K Sell
2,264
-53
-2% -$1.39K ﹤0.01% 4735
2022
Q1 		$75K Buy
2,317
+214
+10% +$7.36K ﹤0.01% 4789
2021
Q4 		$95K Buy
2,103
+542
+35% +$25.7K ﹤0.01% 4635
2021
Q3 		$80K Buy
1,561
+863
+124% +$48.6K ﹤0.01% 4724
2021
Q2 		$54K Sell
698
-135
-16% -$8.35K ﹤0.01% 4982
2021
Q1 		$48K Sell
833
-689
-45% -$46.1K ﹤0.01% 4910
2020
Q4 		$128K Buy
1,522
+772
+103% +$46.7K ﹤0.01% 3863
2020
Q3 		$27K Sell
750
-200
-21% -$6.02K ﹤0.01% 4724
2020
Q2 		$23K Sell
950
-243
-20% -$5.71K ﹤0.01% 4705
2020
Q1 		$21K Buy
+1,193
New +$24.9K ﹤0.01% 4597

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's DNLI Position: Q2 2026 in Review

Osaic Holdings increased its Denali Therapeutics (DNLI) stake by 3.7% in Q2 2026, buying an estimated $12.4K and bringing the position to 17,016 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Osaic Holdings first reported a position in DNLI in Q1 2020 and has held it in 26 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Osaic Holdings held 17,016 shares of Denali Therapeutics worth $438K as of Q2 2026.
  • Osaic Holdings bought 603 Denali Therapeutics shares in Q2 2026, an estimated $12.4K.
  • Denali Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3770 holding.
  • Osaic Holdings first reported a position in Denali Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.